ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EVOTF Evotec SE (PK)

8.98
0.00 (0.00%)
Jun 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price 7.76
Ask Price 8.24
News -
Day High

Low
8.98

52 Week Range

High
25.48

Day Low
Company Name Stock Ticker Symbol Market Type
Evotec SE (PK) EVOTF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 8.98 16:09:51
Open Price Low Price High Price Close Price Prev Close
8.98 8.98
Trades Volume Avg Volume 52 Week Range
0 0.00 - 8.98 - 25.48
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 8.98 USD

Evotec SE (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.59B 115.60M - 781.43M -83.91M -0.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Evotec (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EVOTF Message Board. Create One! See More Posts on EVOTF Message Board See More Message Board Posts

Historical EVOTF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week8.988.988.988.981820.000.00%
1 Month9.859.858.989.44191-0.87-8.83%
3 Months10.4410.448.989.89327-1.46-13.98%
6 Months23.7824.618.9819.312,179-14.80-62.24%
1 Year23.3725.488.9819.931,647-14.39-61.57%
3 Years43.707953.04698.9824.366,387-34.73-79.45%
5 Years27.8053.04698.9827.696,093-18.82-67.70%

Evotec (PK) Description

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology and inflammation. Evotec has long-term discovery alliances with partners including BoehringerIngelheim, CHDI, Genentech, Medimmune/AstraZeneca, Novartis and Ono Pharmaceutical. In addition, the Company has existing development partnerships and product candidates both in clinical and preclinical development. These include partnerships with Boehringer Ingelheim, MedImmune and with Andromeda (Teva) in the field of diabetes and with Roche in the field of Alzheimer's disease. Evotec is built on integrated drug discovery know-how of more than 15 years and is a leading player in the drug discovery field. The Company's headquarters are located in Hamburg, Germany. Additional major operations are based in Abingdon, UK, Gottingen, Munich, Germany, Thane, India and San Francisco, USA. Evotec has more than 600 employees worldwide.

Your Recent History

Delayed Upgrade Clock